BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23853104)

  • 1. Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence.
    Hampl V; Martin C; Aigner A; Hoebel S; Singer S; Frank N; Sarikas A; Ebert O; Prywes R; Gudermann T; Muehlich S
    EMBO Mol Med; 2013 Sep; 5(9):1367-82. PubMed ID: 23853104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.
    Muehlich S; Hampl V; Khalid S; Singer S; Frank N; Breuhahn K; Gudermann T; Prywes R
    Oncogene; 2012 Aug; 31(35):3913-23. PubMed ID: 22139079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
    Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
    Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.
    Hermanns C; Hampl V; Holzer K; Aigner A; Penkava J; Frank N; Martin DE; Maier KC; Waldburger N; Roessler S; Goppelt-Struebe M; Akrap I; Thavamani A; Singer S; Nordheim A; Gudermann T; Muehlich S
    Oncogene; 2017 Jun; 36(24):3464-3476. PubMed ID: 28114277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation.
    Selvaraj A; Prywes R
    J Biol Chem; 2003 Oct; 278(43):41977-87. PubMed ID: 14565952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
    Cen B; Selvaraj A; Prywes R
    J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and Senescence.
    Schreyer L; Mittermeier C; Franz MJ; Meier MA; Martin DE; Maier KC; Huebner K; Schneider-Stock R; Singer S; Holzer K; Fischer D; Ribback S; Liebl B; Gudermann T; Aigner A; Muehlich S
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic localisation of SRF coactivators, MKL1 and MKL2, and their role in dendritic spine morphology.
    Kaneda M; Sakagami H; Hida Y; Ohtsuka T; Satou N; Ishibashi Y; Fukuchi M; Krysiak A; Ishikawa M; Ihara D; Kalita K; Tabuchi A
    Sci Rep; 2018 Jan; 8(1):727. PubMed ID: 29335431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
    Nakagawa K; Kuzumaki N
    Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
    Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
    Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1.
    Yang Y; Chen D; Yuan Z; Fang F; Cheng X; Xia J; Fang M; Xu Y; Gao Y
    Nucleic Acids Res; 2013 Jul; 41(12):6005-17. PubMed ID: 23625963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryoblastic leukemia protein-1 (MKL1): Increasing evidence for an involvement in cancer progression and metastasis.
    Scharenberg MA; Chiquet-Ehrismann R; Asparuhova MB
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1911-4. PubMed ID: 20816842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actin/MKL1 signalling pathway influences cell growth and gene expression through large-scale chromatin reorganization and histone post-translational modifications.
    Flouriot G; Huet G; Demay F; Pakdel F; Boujrad N; Michel D
    Biochem J; 2014 Jul; 461(2):257-68. PubMed ID: 24762104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms.
    Scharenberg MA; Pippenger BE; Sack R; Zingg D; Ferralli J; Schenk S; Martin I; Chiquet-Ehrismann R
    J Cell Sci; 2014 Mar; 127(Pt 5):1079-91. PubMed ID: 24424023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization.
    Muehlich S; Wang R; Lee SM; Lewis TC; Dai C; Prywes R
    Mol Cell Biol; 2008 Oct; 28(20):6302-13. PubMed ID: 18694962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MKL1 mediates TGF-beta1-induced alpha-smooth muscle actin expression in human renal epithelial cells.
    Elberg G; Chen L; Elberg D; Chan MD; Logan CJ; Turman MA
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1116-28. PubMed ID: 18337547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells.
    Du KL; Chen M; Li J; Lepore JJ; Mericko P; Parmacek MS
    J Biol Chem; 2004 Apr; 279(17):17578-86. PubMed ID: 14970199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma.
    Mittermeier C; Konopa A; Muehlich S
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation.
    Smith EC; Teixeira AM; Chen RC; Wang L; Gao Y; Hahn KL; Krause DS
    Blood; 2013 Feb; 121(7):1094-101. PubMed ID: 23243284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4 methyltransferase via a SPOC domain that is required for cytokine-independent proliferation.
    Lee JH; Skalnik DG
    PLoS One; 2012; 7(8):e42965. PubMed ID: 22927943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.